Bulletin
Investor Alert

New York Markets Open in:

July 23, 2019, 6:11 p.m. EDT

Inc. Files An 8-K Results of Operations and Financial Condition

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 23, 2019 (Market Exclusive via COMTEX) -- Inc. Files An 8-K Results of Operations and Financial Condition

INTER PARFUMS INC Exhibit
EX-99.1 2 f8k072319ex99-1_inter.htm OUR PRESS RELEASE DATED JULY 23,...
To view the full exhibit click here

About Inc.

INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

The post Inc. Files An 8-K Results of Operations and Financial Condition appeared first on Market Exclusive .

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.